Neurodegenerative mechanisms in subacute sclerosing panencephalitis

Journal of Child Neurology

Volumn 17, Issue 10, 2002, Pages 725-730

  Hayashi, Masaharu ^a   Arai, Nobutaka ^a   Satoh, Junichi ^a   Suzuki, Hisaharu ^b   Katayama, Kazunobu ^c   Tamagawa, Kimiko ^d   Morimatsu, Yoshio ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b Medical Center for the Handicapped   (Japan)

^c Medical Corporation Matsuo Clinic   (Japan)

^d TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ALPHA INTERFERON; CELL DNA; GLUTAMATE TRANSPORTER; METHISOPRINOL; RNA;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; AUTOPSY; BRAIN CORTEX; BRAIN INFECTION; BRAIN NERVE CELL; CELL NUCLEUS; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; CYTOPLASM; DISEASE DURATION; DISEASE MARKER; DNA DAMAGE; FEMALE; GLIA CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID PEROXIDATION; LIPID STORAGE; MALE; MEASLES VIRUS; NERVE CELL LESION; NERVE DEGENERATION; NEUROPATHOLOGY; NICK END LABELING; OXIDATIVE STRESS; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REGULATORY MECHANISM; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS MUTATION; WHITE MATTER;

EID: 0036823978     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738020170101101     Document Type: Article

References (23)

1. Swoveland PT, Johnson KP: Subacute sclerosing panencephalitis and other paramyxovirus infection, in McKendall RR (ed): Handbook of Clinical Neurology, Vol. 12 (56), Viral disease. Amsterdam, Elsevier Science Publishers BV, 1989, 417-437.
2. Isaacson SH, Asher DM, Godec MS, et al: Widespread, restricted low-level measles virus infection of brain in a case of subacute sclerosing panencephalitis. Acta Neuropathol 1996;91:135-139.
3. Seto T, Ayata M, Hayashi K, et al: Different transcriptional expression of the matrix gene of the two sibling viruses of the subacute sclerosing panencephalitis virus (Osaka-2 strain) isolated from a biopsy specimen of patient brain. J Neurovirol 1999;5:151-160.
4. Allen IV, McQuaid S, McMahon J, et al: The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J Neuropathol Exp Neurol 1996;55:471-480.
5. McQuaid S, McMahon J, Herron B, Cosby SL: Apoptosis in measles virus infected human central nervous system tissues. Neuropathol Appl Neurobiol 1997;23:218-224.
6. Anlar B, Söylemezoglu F, Elibol B, et al: Apoptosis in brain biopsies of subacute sclerosing panencephalitis patients. Neuropediatrics 1999;30:239-242.
7. Simonian NA, Coyle JT: Oxidative stress in neurodegenerative disease. Annu Rev Pharmacol Toxicol 1996;36:83-106.
8. Rothstein JD, van Kammen M, Levey AI, et al: Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84.
9. Kumada S, Hayashi M, Mizuguchi M, et al: Cerebellar degeneration in hereditary dentatorubral-pallidoluysian atrophy and Machado-Joseph disease. Acta Neuropathol 2000;99:48-54.
10. Takayama S, Iwasaki Y, Yamanouchi H, et al: Characteristic clinical features in a case of fulminant subacute sclerosing panencephalitis. Brain Dev 1994;16:132-135.
11. Nunomura A, Perry G, Pappolla MA, et al. Neuronal oxidative stress precedes amyloid-β deposition in Down syndrome. J Neuropathol Exp Neurol 2000;59:1011-1017.
12. Nunomura A, Perry G, Gjumrakch A, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759-767.
13. Anlar B, Yalaz K, Öktem F, Köse G: Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology 1997;48:526-528.
14. Pignata C, Fiore M, de Filippo S, et al: Apoptosis as a mechanism of peripheral blood mononuclear cell death after measles and varicella-zoster virus infections in children. Pediatr Res 1998;43:77-83.
15. Toyokuni S: Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999;49:91-102.
16. Bogdanov M, Brown RH Jr, Matson W, et al: Increased oxidative damage to DNA in ALS patients. Free Radic Biol Med 2000;29:652-658.
17. Sayre LM, Zalasko DA, Harris PLR, et al: 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997;68:2092-2097.
18. Yoritaka A, Hattori N, Uchida K, et al: Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A 1996;93:2696-2701.
19. Rothstein JD, Martin LJ, Levey AI, et al: Localization of neuronal and glial transporters. Neuron 1994;13:713-725.
20. Bar-Peled O, Ben-Hur H, Biegon A, et al: Distribution of glutamate transporter subtypes during human brain development. J Neurochem 1997;69:2571-2580.
21. Li S, Mallory M, Alford M, et al: Glutamate transporter alterations in Alzheimer diseases are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 1997;56:901-911.
22. Wisniewski HM, Dymecki J, Wegiel J, et al: Neurofibrillary pathology in subacute sclerosing panencephalitis. Dementia 1991;2:133-141.
23. McQuaid S, Allen IV, McMahon J, Kirk J: Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: A combined in situ hybridization and immunocytochemical investigation. Neuropathol Appl Neurobiol 1994;20:103-110.